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Nontypeable Haemophilus influenzae (NTHI) initiates infection by colonizing the upper respiratory tract
mucosa. NTHI disease frequently occurs in the context of respiratory tract inflammation, where organisms
encounter damaged epithelium and exposed basement membrane. In this study, we examined interactions
between the H. influenzae Hap adhesin and selected extracellular matrix proteins. Hap is an autotransporter
protein that undergoes autoproteolytic cleavage, with release of the adhesive passenger domain, Haps, from the
bacterial cell surface. We found that Hap promotes bacterial adherence to purified fibronectin, laminin, and
collagen IV and that Hap-mediated adherence is enhanced by inhibition of autoproteolysis. Adherence is
inhibited by pretreatment of bacteria with a polyclonal antiserum recognizing Haps. Purified Haps binds with
high affinity to fibronectin, laminin, and collagen IV but not to collagen II. Binding of Haps to fibronectin
involves interaction with the 45-kDa gelatin-binding domain but not the 30-kDa heparin-binding domain of
fibronectin. Taken together, these observations suggest that interactions between Hap and extracellular matrix
proteins may play an important role in NTHI colonization of the respiratory tract.
mediated attachment to both fibronectin and heparin-binding
growth-associated molecule, although nonpiliated strains were
also capable of binding to these proteins (26).
In addition to producing pili, H. influenzae elaborates numerous nonpilus adhesins. One of these adhesins, called Hap,
is ubiquitous among both nontypeable (nonencapsulated) and
type b encapsulated clinical isolates and promotes binding to a
variety of cultured human epithelial cells (20). Hap is a member of the autotransporter family of gram-negative bacterial
virulence factors (7). In recent work, we demonstrated that the
Hap autotransporter consists of an amino-terminal signal sequence that directs transport across the bacterial inner membrane, a 110-kDa adhesive passenger domain called Haps, and
a 45-kDa translocator domain called Hap␤ (8). As with other
autotransporters, the translocator domain is thought to insert
itself into the outer membrane as a pore-forming beta-barrel
through which the adhesive passenger domain is extruded to
reach the bacterial cell surface. In addition to its adhesive
activity, the Haps passenger domain also harbors serine protease activity that directs autoproteolytic cleavage of Haps
from Hap␤ under certain circumstances. Mutation of the Haps
active-site serine residue at position 243 to an alanine
(HapS243A) inhibits release of Haps from the bacterial surface
and results in increased adherence to epithelial cells.
In the present study, we sought to determine whether Hap is
capable of interacting with ECM proteins. In initial experiments, we found that Hap promotes attachment of bacteria to
purified fibronectin, laminin, and collagen IV. In addition, we
observed that purified Haps passenger domain binds with high
affinity to these ECM proteins and that Haps interacts specifically with the 45-kDa gelatin-binding domain of fibronectin.
These results provide additional insight into the mechanisms
by which H. influenzae colonizes the human respiratory tract.

Extracellular matrix (ECM) consists of a diverse group of
proteins that form the scaffolding responsible for the development, growth, and maintenance of mammalian tissues. In epithelial tissues, certain ECM proteins function together with
cells to form barriers intended to prevent penetration of these
tissues by microorganisms. Both pathogenic and commensal
bacteria have evolved mechanisms designed to subvert epithelial barriers (3, 5, 14, 23, 28). These mechanisms include bacterial surface proteins called adhesins that bind to ECM and
bacterial proteases that degrade ECM components and permit
migration of bacteria to deeper tissue spaces where they may
gain easier access to nutrients and safe harbor from the host
immune response.
Haemophilus influenzae is a gram-negative bacterium that is
often found as a commensal inhabitant of the respiratory tract
in healthy adults but also represents a common cause of both
localized respiratory tract and invasive systemic disease (25).
In studies examining interactions between H. influenzae clinical
isolates and human respiratory tract tissue, bacteria were often
associated with damaged epithelium and exposed ECM (16,
17). Furthermore, examination of bronchial biopsies from patients with persistent H. influenzae bronchitis revealed organisms in the subepithelial compartment, suggesting that this
pathogen is capable of penetrating the basement membrane
(11). Additional analysis of interactions between clinical isolates and purified ECM components demonstrated that many
H. influenzae strains were capable of binding to fibronectin,
laminin, and various collagens (2, 27). In recent work, Virkola
and coworkers found that H. influenzae hemagglutinating pili
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TABLE 1. Bacterial strains and plasmids
Strain or plasmid

H. influenzae
DB117
Plasmids
pGJB103
pJS106

Reference

Laboratory strain, rec-1, capsuledeficient serotype d

19

E. coli-H. influenzae shuttle vector, Tcr
pGJB103 with a 6.7-kb PstI fragment
containing hap
pJS106 with S243A mutation

24
20
8

MATERIALS AND METHODS
Bacterial strains and plasmids. The bacterial strains and plasmids used in this
study are listed in Table 1. H. influenzae strains were grown in brain heart
infusion broth supplemented with NAD and hemin (BHIs) or on BHIs agar or
chocolate agar as described previously (1) and were stored at ⫺80°C in brain
heart infusion broth with 20% glycerol. Tetracycline was used at a concentration
of 5 g/ml.
SEM of bacterial interactions with purified ECM proteins. Glass coverslips
were spotted with 30-l aliquots of plasma fibronectin, laminin, or collagen IV at
1 mg/ml and were incubated for 15 min at room temperature and then were
washed once with phosphate-buffered saline (PBS). Subsequently, the coverslips
were added to petri dishes containing suspensions of bacteria that had been
incubated in BHIs to late exponential phase (optical density at 600 nm ⫽ 0.9)
and then chilled to stop growth. Coverslips were incubated while shaking in the
bacterial suspensions for 2 h at room temperature, washed once with PBS, and
then fixed with glutaraldehyde and prepared for scanning electron microscopy
(SEM). Bacterial association was scored by an independent observer.
Quantitative adherence assays. Adherence assays were performed as described previously (21). Twenty-four-well tissue culture plates coated with human
plasma fibronectin, murine laminin, or murine collagen IV (BD Biosciences)
were rehydrated in 0.5 ml of minimum essential medium (Sigma), and plates
were warmed to 37°C for 1 h in a tissue culture incubator infused with 5% CO2.
Percent adherence was calculated by dividing the number of adherent CFU per
well by the number of inoculated CFU.
Far-Western dot immunoblots. Purified human plasma fibronectin, murine
laminin, and murine collagen IV were obtained from BD Biosciences. Fibronectin fragments and bovine serum albumin (BSA) were obtained from Sigma. Haps
was purified as described previously (8). ECM proteins were spotted in 50-g
quantities into wells of a 96-well dot blot manifold apparatus holding a nitrocellulose membrane. Samples were incubated for 30 min and then pulled through
the membrane by vacuum suction. Subsequently, the membrane was blocked in
Tris-buffered saline plus 5% skim milk for 1 h. The membrane was then incubated with purified Haps diluted to a final concentration of 10 g/ml in Trisbuffered saline plus 5% skim milk. Next, the membrane was incubated with
anti-Haps antiserum RabK2 (9) diluted 1:1,000 and then a secondary anti-rabbit
immunoglobulin G antibody conjugated to horseradish peroxidase (Sigma) diluted 1:10,000. Detection of Haps binding was accomplished by incubating the
membrane in a chemiluminescent horseradish peroxidase substrate solution
(Pierce, Rockford, Ill.) and exposing the membrane to film.
Enzyme-linked immunosorbent assays (ELISAs). Collagen II-coated 96-well
plates were prepared using purified bovine tracheal collagen II (Sigma) and a
protocol provided by the manufacturer. In particular, collagen II was dissolved in
ice-cold 0.5 M acetic acid, pH 2.0, to a final concentration of 1 mg/ml. Wells of
tissue culture-treated 96-well plates (Costar) were incubated with 40 l of dissolved collagen at room temperature for 1 h with gentle shaking and were then
washed once with PBS. In control plates, coating was confirmed using mouse
ascites fluid against collagen II (Sigma), a secondary anti-mouse antibody conjugated to horseradish peroxidase, and a chromogenic horseradish peroxidase
substrate (Kirkegaard & Perry Laboratories, Gaithersburg, Md.), followed by
measurement of absorbance at 650 nm. Ninety-six-well plates coated with fibronectin, laminin, and collagen IV were obtained from BD Biosciences.
Wells were blocked with 200 l of PBS–1% BSA for 1 h at room temperature
and then washed once with PBS. One hundred microliters of purified Haps or
purified HifB (22) diluted in PBS plus 1% BSA to final concentrations of 0.5, 1,
5, 10, 50, or 100 nM was added to triplicate wells, and plates were incubated for
1 h at room temperature. Wells were then incubated successively for 1 h with
anti-Haps antiserum RabK2 or anti-HifB antiserum Rab452 (22), each diluted
1:1,000 in PBS–1% BSA, and then a secondary anti-rabbit immunoglobulin G

antibody conjugated to horseradish peroxidase diluted 1:10,000 in PBS–1% BSA.
Wells were washed three times with PBS after each incubation step. After the
final wash, binding by Haps or HifB binding was detected by incubating wells with
200 l of a chromogenic horseradish peroxidase substrate (Kirkegaard & Perry
Laboratories) and measurement of absorbance at 650 nm. Data were analyzed
using PadPrism software (version 3.0a).

RESULTS
Hap promotes adherence of bacteria to fibronectin, laminin,
and collagen IV. In considering how Hap might contribute to
colonization of the human respiratory tract by H. influenzae, we
first sought to determine whether expression of Hap could
promote binding of live bacteria to purified ECM proteins. In
initial experiments we used SEM to examine binding of H.
influenzae strains DB117/pHapS243A, which expresses a derivative of Hap that does not undergo autoproteolysis and therefore retains all of the Haps adhesive passenger domain on the
bacterial cell surface, and H. influenzae strain DB117/pGJB103
(empty vector). Glass coverslips were spotted in duplicate with
aqueous solutions of purified plasma fibronectin, laminin, or
collagen IV and then incubated for 2 h with late-exponentialphase bacterial cultures. Assessment of bacterial adherence by
DB117/pHapS243A revealed numerous organisms associated
in clusters with all ECM proteins (Fig. 1). In contrast, examination of adherence by DB117/pGJB103 revealed very few
organisms on any of the coverslips (Fig. 1).
To extend these results, we quantitated Hap-mediated adherence to ECM proteins in standard 30-min adherence assays
using tissue culture plates coated with preparations of purified
plasma fibronectin, laminin, or collagen IV. As shown in Fig. 2,
DB117 expressing wild-type Hap adhered significantly to each
of the ECM proteins at levels ranging from 10 to 15% of the
inoculum, while DB117 harboring vector alone exhibited minimal adherence. Since processing of the wild-type Hap protein
culminates in autoproteolytic cleavage of the Haps adhesive
domain from a portion of the precursor population, we next
evaluated bacteria expressing HapS243A. As expected, DB117
expressing HapS243A adhered at higher levels to each of the
ECM proteins than did bacteria expressing wild-type Hap (Fig.
2), consistent with earlier studies of Hap-mediated adherence
to epithelial cells (9).
In additional experiments, we examined the ability of
RabK2, a polyclonal antiserum raised against purified Haps, to
inhibit Hap-mediated adherence to ECM proteins. As shown
in Fig. 2, preincubation of DB117/pHapS243A with increasing
concentrations of RabK2 resulted in dose-dependent decreases in adherence to each of the ECM proteins. Inhibition
by RabK2 was most striking in experiments with collagen IV, in
which even a 1:1,000 dilution of antiserum caused marked
decreases in adherence relative to the untreated control. In
assays with fibronectin and laminin, significant decreases in
adherence were observed with 1:500 and 1:100 dilutions of
RabK2. In contrast, preincubation of DB117/pHapS243A with
a 1:100 dilution of preimmune rabbit serum had no significant
effect on adherence (97.0% ⫾ 12.8% of untreated control with
fibronectin, 103.2% ⫾ 7.9% of untreated control with laminin,
and 104.1% ⫾ 3.6% of untreated control with collagen IV
[means ⫾ standard errors of the means]). Taken together,
these results strongly suggest that Haps present on the surface
of bacterial cells is capable of interacting with fibronectin,
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laminin, and collagen IV to promote adherence of live organisms to each of these ECM proteins.
Beyond being present in plasma and ECM, fibronectin is
associated with the surface of epithelial cells. Accordingly, we
wondered whether fibronectin might serve as a receptor in
interactions between bacteria expressing Hap and cultured epithelial cells. To explore this possibility, we preincubated confluent monolayers of Chang or A549 epithelial cells with various dilutions of a polyclonal antiserum directed against
fibronectin (Sigma) and then inoculated DB117 expressing
HapS243A. In uninfected control samples, fluorescence mi-

croscopy confirmed antibody binding to cells as large aggregates, suggesting clumps of fibronectin (data not shown). In
samples inoculated with DB117/pHapS243A, even with the
highest concentration of antifibronectin antiserum, we observed no reduction in adherence (data not shown), suggesting
that fibronectin is probably not the receptor for Hap on epithelial cells. Alternatively, cellular fibronectin may be one of
several receptors present in quantities large enough that blockage of fibronectin does not interfere with overall adherence
levels.
Purified Haps binds to purified fibronectin, laminin, and

Downloaded from http://iai.asm.org/ on January 13, 2014 by Washington University in St. Louis

FIG. 1. SEM of H. influenzae strains DB117/pGJB103 and DB117/pHapS243A after incubation with ECM proteins. Shown are representative
fields of SEM samples with DB117 expressing empty vector (top panels) or HapS243A (bottom panels). Suspensions of bacteria were incubated
with glass slides previously coated with purified fibronectin (A and D), laminin (B and E), or collagen IV (C and F). Bars correspond to 10 m.
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collagen IV. To extend our observations with bacteria expressing Hap, we examined whether purified Haps (the Hap adhesive domain) could interact with fibronectin, laminin, and collagen IV in protein binding assays. Initially, 50-g samples of
these ECM proteins were immobilized on a nitrocellulose
membrane, which was then overlaid with purified Haps diluted
to a final concentration of 10 g/ml. As shown in Fig. 3,
far-Western immunoblot assays demonstrated binding of Haps
to fibronectin, laminin, and collagen IV. No binding of Haps
was detected to a control spot containing 50 g of BSA. Since
many fibronectin-binding proteins are known to interact with
specific domains of fibronectin, we prepared two additional
spots containing purified fibronectin proteolytic fragments
(Sigma), one representing the 30-kDa heparin-binding domain
and the other representing the 45-kDa gelatin-binding domain.
In this experiment, Haps bound to the 45-kDa fragment but
not the 30-kDa fragment, suggesting that Hap interacts specifically with the fibronectin gelatin-binding region (Fig. 3).
Finally, we attempted to quantitate the strength of Haps
binding interactions with ECM proteins by ELISA. Samples of
purified Haps at concentrations ranging from 0.5 to 100 nM

FIG. 3. Far-Western dot immunoblot of purified Haps binding to
ECM proteins. Samples were loaded with 50 g of purified protein as
follows: lane 1, BSA; lane 2, fibronectin; lane 3, fibronectin 30-kDa
heparin-binding fragment; lane 4, fibronectin 45-kDa gelatin-binding
fragment; lane 5, laminin; lane 6, collagen IV. Immunoblotting was
performed with antiserum RabK2 after incubation of the membrane
with purified Haps diluted to 10 g/ml.

were added to wells of 96-well plates coated with plasma fibronectin, laminin, collagen IV, or collagen II, and binding was
detected with a polyclonal antiserum directed against Haps.
Dose-dependent binding of Haps to wells coated with plasma
fibronectin, laminin, and collagen IV was observed (Fig. 4).

FIG. 4. Dose-dependent binding of purified Haps to ECM proteins.
Shown are results of binding of increasing concentrations of purified
Haps to fibronectin, collagen IV, laminin, and collagen II by purified
Haps. Binding was quantitated by ELISA at an absorbance of 650 nm.
Points represent the means (error bars, standard errors of the means)
of measurements made in triplicate. Binding curves were calculated by
nonlinear regression analysis using GraphPad Prism software (version
3.0).

Downloaded from http://iai.asm.org/ on January 13, 2014 by Washington University in St. Louis

FIG. 2. Adherence to ECM proteins by H. influenzae strain DB117 expressing wild-type Hap or HapS243A and inhibition of adherence by
anti-Haps antiserum. Adherence to fibronectin, laminin, and collagen IV was calculated by dividing the number of adherent bacteria by the number
of inoculated bacteria. Error bars represent the mean ⫾ standard error of the mean of measurements made in triplicate from representative
experiments. Adherence was inhibited by increasing concentrations of antiserum RabK2, which reacts with Haps. A 1:100 dilution of preimmune
rabbit serum had no effect on adherence. The x axis varies from one panel to the next.
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DISCUSSION
In previous work, we demonstrated that Hap promotes bacterial adherence to cultured epithelial cells (20). Inhibition of
autoproteolysis by mutation of the Hap active-site serine residue results in retention of the Haps passenger domain on the
bacterial cell surface and increased adherence to epithelial
cells (9). In the present study, we found that Hap also promotes bacterial adherence to the ECM proteins fibronectin,
laminin, and collagen IV. Similar to the situation with epithelial cells, bacteria expressing HapS243A adhere more efficiently to ECM proteins than bacteria expressing wild-type
Hap, suggesting that Haps possesses the binding domains responsible for interactions with ECM proteins.
Inhibition of Hap-mediated adherence to fibronectin, laminin, and collagen IV by antiserum RabK2 provides further
evidence for the presence of ECM binding domains within
Haps. RabK2 reacts specifically with epitopes in Haps and does
not react with the Hap␤ translocator domain. It is possible that
some antibodies in RabK2 react with the C terminus of Haps
and obscure a binding domain in the N terminus of Hap␤.
However, a binding domain in Hap␤ would presumably be
equally abundant on bacteria expressing either wild-type Hap
or HapS243A. The difference in adherence efficiencies between DB117/pJS106 and DB117/pHapS243A argues against
this possibility. Studies with Hap in-frame deletion mutants
have focused our search for ECM binding domains on the
C-terminal half of Haps (D. L. Fink and J. W. St. Geme III,
unpublished observations), and scanning mutagenesis within
this region may eventually pinpoint individual residues involved in binding domains.
Examination of interactions between Haps and fibronectin
fragments suggests that Hap may interact specifically with the
45-kDa gelatin-binding domain of fibronectin. These data do
not exclude the possibility of interactions between Hap and
other fibronectin domains, which remain to be evaluated. Successful mapping of fibronectin binding domains has been
achieved for certain bacterial adhesins by far-Western immunoblot of fibronectin fragments produced by limited proteoly-

sis with thermolysin (Magnus Höök, personal communication).
This strategy has so far been unsuccessful with purified Haps,
further suggesting that Hap may recognize a conformational
epitope on natively folded fibronectin. Future studies will evaluate interactions between Haps and purified thermolysin-digested fibronectin fragments.
Our results demonstrate that Hap promotes adherence to
three distinct ECM proteins. Similar broad-spectrum binding
profiles have been reported for several other bacterial adhesins, including FnbpA and Emp of Staphylococcus aureus,
Ace of Enterococcus faecalis, and YadA of Yersinia spp. (4, 10,
13). Purified Haps binds to fibronectin, laminin, and collagen
IV with comparably high affinities in ELISAs, suggesting that
Hap may interact with a particular structural epitope present
on all three proteins. Candidates for this type of receptor
structure include complex sugars of glycosylated proteins, as is
the case with binding of H. influenzae pili and the HMW1
adhesin to their respective receptors. However, preliminary
studies with chemical or enzymatic disruption of carbohydrate
structures on fibronectin and laminin indicate that sugars may
not be involved in interactions between Hap and ECM proteins. Hap may instead recognize a protein fold common
among fibronectin, laminin, and collagen IV. Curiously, the
binding constants for interactions between purified Haps and
ECM proteins are also similar to those calculated for binding
of Haps to Chang and A549 epithelial cells (Fink et al., submitted for publication), raising the possibility that an ECM
protein may be the cellular receptor for Hap. Although pretreatment of cells with antifibronectin antibodies does not affect Hap-mediated bacterial adherence, any of a number of
cell-associated ECM proteins could potentially serve as a receptor. Alternatively, the cellular Hap receptor may possess a
conformational epitope similar to those present in ECM proteins.
In considering the role of Hap in NTHI colonization of the
respiratory tract, it is noteworthy that fibronectin, laminin, and
collagen IV are all components of basement membrane underlying respiratory epithelium. Additionally, fibronectin is
present on the surface of epithelial cells. In contrast to the
situation with collagen IV, Haps does not bind to collagen II,
which is found mainly in cartilage and would not typically be
encountered by H. influenzae during natural infection. NTHI
disease is often associated with underlying chronic obstructive
pulmonary disease or recent respiratory viral infection (6, 12,
15). Given that respiratory inflammation involves increased
production of fibronectin and collagen and deposition of these
proteins on epithelial cells (18), Hap-mediated bacterial attachment to ECM may be an important factor in initial colonization of the inflamed respiratory tract as well as contiguous
spread of organisms to new sites of infection. Furthermore,
damaged epithelium and exposed basement membrane are
often found in the context of respiratory tract inflammation.
NTHI associates preferentially with damaged epithelium in
studies with nasopharyngeal tissue and explants from persistently infected patients (11, 16), and Hap may contribute to
these interactions.
In summary, the H. influenzae Hap adhesin promotes bacterial adherence to fibronectin, laminin, and collagen IV. Retention of the Haps passenger domain on the bacterial cell
surface enhances adherence to these ECM proteins, while
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Conversely, Haps did not bind appreciably to wells coated with
collagen II (Fig. 4) or to wells coated with BSA alone (data not
shown). As a negative control in all of the ELISAs, we examined binding of purified HifB, a periplasmic chaperone involved in the assembly of H. influenzae pili and lacking adhesive activity. No appreciable binding of HifB to any of the
ECM proteins was detected (data not shown). Nonlinear regression analysis of the ELISA data was used to estimate
dissociation constants for the binding interactions between purified Haps and each of the ECM proteins. The binding constants predicted from this analysis were approximately 15 nM
for plasma fibronectin, 20 nM for collagen IV, and 35 nM for
laminin, suggesting that Haps binding to ECM ligands is a
strong interaction and roughly equivalent among the three
proteins examined. The R2 values for all of the predicted binding curves ranged from 0.97 to 0.99, indicating excellent fit of
the curves to the ELISA data. Differences in the absolute
signal intensity between individual experiments likely reflect
differences in incubation time with the detection substrate and
not differences in binding affinities.
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treatment with an antiserum reactive against Haps inhibits
adherence. In assays with purified proteins, Haps binds with
high affinity to fibronectin, laminin, and collagen IV. Purified
Haps interacts specifically with the 45-kDa gelatin-binding domain of fibronectin and not with the 30-kDa heparin-binding
domain. These data suggest a possible mechanism for previously observed interactions between nontypeable H. influenzae
and ECM and further advocate that these interactions may be
important to colonization of the respiratory tract by NTHI.
Future studies will seek to identify the Haps binding domains
responsible for adherence to ECM proteins and their cognate
receptor sites on fibronectin, laminin, and collagen IV.
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